富血小板血浆改善肩袖撕裂疼痛与功能的系统评价与meta分析
该系统评价与meta分析纳入18项1级研究(其中17项1116例可定量分析),评估PRP治疗肩袖相关异常的效果。结果显示PRP组Constant评分短期和长期显著更优,VAS短期显著改善,长期再撕裂率显著降低,但功能改善未达最小临床重要差异。
要点
- PRP组Constant评分短期(WMD 2.89)和长期(WMD 2.66)显著优于对照组。
- PRP组VAS短期显著改善(WMD -0.45),长期再撕裂风险显著降低(OR 0.34)。
- 功能改善均未达最小临床重要差异,且研究异质性大、方法学质量有限。
核心结论
- 接受PRP治疗的肩袖相关异常患者长期再撕裂率显著降低。
- PRP组多项功能结局显著改善,但均未达各自的最小临床重要差异。
- PRP可能对临床结局有积极影响,但数据有限、研究异质性和方法学质量差妨碍确切结论。
研究设计与样本
- 系统评价与meta分析,遵循PRISMA指南筛选文献。
- 纳入18项1级研究,其中17项(1116例患者)纳入定量分析。
- 采用100分改良Coleman方法学评分评估质量,平均79.4±10.39。
- 使用漏斗图和Egger检验筛查发表偏倚,并做敏感性分析。
主要发现
- PRP组Constant评分短期显著更优(WMD 2.89,95%CI 0.89-4.90,P<.01),长期亦显著更优(WMD 2.66,95%CI 1.13-4.19,P<.01)。
- PRP组VAS评分短期显著改善(WMD -0.45,95%CI -0.75至-0.15,P<.01)。
- PRP组Sugaya IV和V级再撕裂长期显著减少(OR 0.34,95%CI 0.20-0.57,P<.01)。
- 多肌腱撕裂的PRP治疗患者再撕裂风险降低(OR 0.28,95%CI 0.13-0.60,P<.01)。
- 富白细胞PRP组Constant评分显著优于贫白细胞PRP组,但VAS无差异;PRP凝胶组Constant评分高于对照,非凝胶组无此差异,VAS均无差异。
关键数值与推荐
- 长期再撕裂风险降低见于贫白细胞PRP(OR 0.36,95%CI 0.16-0.82)和富白细胞PRP(OR 0.32,95%CI 0.16-0.65),均P<.05。
- 长期再撕裂风险降低亦见于非凝胶PRP(OR 0.42,95%CI 0.23-0.76)和凝胶PRP(OR 0.17,95%CI 0.05-0.51),均P<.01。
临床怎么用
- PRP可能降低肩袖相关异常患者的长期再撕裂风险,但功能改善幅度未达最小临床重要差异。
- 富白细胞PRP在Constant评分上可能优于贫白细胞PRP,但VAS无差异。
- PRP凝胶在Constant评分上可能优于对照,非凝胶PRP无此优势,但VAS均无差异。
- 临床决策需权衡PRP的潜在获益与有限证据质量及研究异质性。
局限性
- 数据有限,研究间存在异质性,方法学质量较差,妨碍确切结论。
- 功能改善虽显著但均未达最小临床重要差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Many clinical trials have investigated the use of platelet-rich plasma (PRP) to treat rotator cuff-related abnormalities. Several meta-analyses have been published, but none have focused exclusively on level 1 randomized controlled trials. PURPOSE: To assess the efficacy of PRP for rotator cuff-related abnormalities and evaluate how specific tendon involvement, the inclusion of leukocytes, and the use of gel/nongel formulations affect pain and functional outcomes. STUDY DESIGN: Systematic review and meta-analysis. METHODS: The literature was screened following PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. Baseline, short-term, and long-term data were extracted for the Constant score, University of California, Los Angeles (UCLA) score, visual analog scale (VAS) for pain, retear rate, Simple Shoulder Test (SST), and American Shoulder and Elbow Surgeons (ASES) score. The 100-point modified Coleman Methodology Score (CMS) was used to assess methodological quality. Funnel plots and the Egger test were used to screen for publication bias, and sensitivity analysis was performed to evaluate the effect of potential outliers. RESULTS: A total of 18 level 1 studies were included in this review, 17 (1116 patients) of which could be included in quantitative analysis. The mean modified CMS was 79.4 ± 10.39. The Constant scores of patients who received PRP were significantly better short term (weighted mean difference [WMD], 2.89 [95% CI, 0.89-4.90]; P < .01) and long term (WMD, 2.66 [95% CI, 1.13-4.19]; P < .01). The VAS scores were significantly improved short term (WMD, -0.45 [95% CI, -0.75 to -0.15]; P < .01). Sugaya grade IV and V retears in PRP-treated patients were significantly reduced long term (odds ratio [OR], 0.34 [95% CI, 0.20-0.57]; P < .01). In PRP-treated patients with multiple tendons torn, there were reduced odds of retears (OR, 0.28 [95% CI, 0.13-0.60]; P < .01). Patients who received leukocyte-rich PRP had significantly better Constant scores compared with the leukocyte-poor PRP group, but there was no difference in VAS scores. Patients receiving PRP gel reported higher Constant scores compared with the controls, whereas those receiving nongel PRP treatments did not, although there was no difference in VAS scores. Long-term odds of retears were decreased, regardless of leukocyte content (leukocyte-poor PRP: OR, 0.36 [95% CI, 0.16-0.82]; leukocyte-rich PRP: OR, 0.32 [95% CI, 0.16-0.65]; all P < .05) or usage of gel (nongel: OR, 0.42 [95% CI, 0.23-0.76]; gel: OR, 0.17 [95% CI, 0.05-0.51]; all P < .01). CONCLUSION: Long-term retear rates were significantly decreased in patients with rotator cuff-related abnormalities who received PRP. Significant improvements in PRP-treated patients were noted for multiple functional outcomes, but none reached their respective minimal clinically important differences. Overall, our results suggest that PRP may positively affect clinical outcomes, but limited data, study heterogeneity, and poor methodological quality hinder firm conclusions.
引用
- Chen X, Jones IA, Togashi R, et al. Use of Platelet-Rich Plasma for the Improvement of Pain and Function in Rotator Cuff Tears: A Systematic Review and Meta-analysis With Bias Assessment. Am J Sports Med. 2019. PMID: 31743037. doi:10.1177/0363546519881423
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。